PACLITAXEL , Trodelvy 200 mg powder for concentrate for solution for infusion, Doxorubicin Teva 2 mg/ml Concentrate for Solution for Infusion
GS-US-682-6769
Phase 3 small_molecule active
Quick answer
PACLITAXEL , Trodelvy 200 mg powder for concentrate for solution for infusion, Doxorubicin Teva 2 mg/ml Concentrate for Solution for Infusion for Recurrent or Persistent Endometrial Cancer is a Phase 3 program (small_molecule) at Gilead Sciences International Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Gilead Sciences International Limited
- Indication
- Recurrent or Persistent Endometrial Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active